QuantLogix's current estimate for nference, published 2026-09-27 — in line with the last disclosed round of $861M (2022-Q4).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$861M
2022-Q4
weight 0.07
How this price has held up
No round has priced for nference since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, nference, 2026-09-27 (145f9f6ee3dbfe02).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is nference going public?
No. nference is private and has not filed to go public. There is no S-1 on file.
What is nference's valuation in 2026?
nference is valued at $861M as of 2022-Q4, set by its Later Stage VC ($2.74M, Nov 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has nference filed an S-1?
No public S-1 is on file for nference.
How much has nference raised?
nference has raised $147.74M in total, most recently a Later Stage VC of $2.74M in Nov 2022.
Is nference publicly traded — can you buy nference stock?
No. nference is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for nference on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2013
HQ
Cambridge, MA
Employees
336
Total Raised
$147.74M
Last Round
Later Stage VC — $2.74M (Nov 2022)
IPO Status
private
Fundraising Status
Later Stage VC · $2.74M · 3y 10mo ago
privateTotal raised $147.74M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Later Stage VC
$2.74M
Nov 2022
—
$861M
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for nference — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-19. Re-checked weekly.
Talent Signal
No public careers page or job board could be found for nference as of 2026-09-16. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q4. Refreshed quarterly.